Education
About Us
Working with TipRanks
Follow Us
Aion Therapeutic Inc (TSE:AION)
:AION
RESEARCH TOOLSreports
Total Valuation
Aion Therapeutic Inc has a market cap or net worth of C$4.84M. The enterprise value is C$2.29M.
Market CapC$4.84M
Enterprise ValueC$2.29M
Share Statistics
Aion Therapeutic Inc has 483,549,260 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding483,549,260
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aion Therapeutic Inc’s return on equity (ROE) is 1.62 and return on invested capital (ROIC) is 66.52%.
Return on Equity (ROE)1.62
Return on Assets (ROA)-8.95
Return on Invested Capital (ROIC)66.52%
Return on Capital Employed (ROCE)0.31
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.52
Inventory Turnover0.51
Valuation Ratios
The current PE Ratio of Aion Therapeutic Inc is -0.84. Aion Therapeutic Inc’s PEG ratio is 0.06.
PE Ratio-0.84
PS Ratio0.00
PB Ratio-0.54
Price to Fair Value-1.37
Price to FCF-35.36
Price to Operating Cash Flow-35.36
PEG Ratio0.06
Income Statement
In the last 12 months, Aion Therapeutic Inc had revenue of 367.48K and earned -6.29M in profits. Earnings per share was -0.02.
Revenue367.48K
Gross Profit163.12K
Operating Income-1.19M
Pretax Income-6.29M
Net Income-6.29M
EBITDA-6.07M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -1.55M and capital expenditures 2.00, giving a free cash flow of -1.55M billion.
Operating Cash Flow-1.55M
Free Cash Flow-1.55M
Free Cash Flow per Share>-0.01
Dividends & Yields
Aion Therapeutic Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-2.57
52-Week Price Change0.00%
50-Day Moving Average0.01
200-Day Moving Average0.01
Relative Strength Index (RSI)70.83
Average Volume (3m)46.78K
Important Dates
Aion Therapeutic Inc upcoming earnings date is Dec 17, 2025, TBA Not Confirmed.
Last Earnings DateSep 26, 2024
Next Earnings DateDec 17, 2025
Ex-Dividend Date―
Financial Position
Aion Therapeutic Inc as a current ratio of 0.12, with Debt / Equity ratio of -30.32%
Current Ratio0.12
Quick Ratio0.03
Debt to Market Cap0.38
Net Debt to EBITDA-0.33
Interest Coverage Ratio-6.95
Taxes
In the past 12 months, Aion Therapeutic Inc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Aion Therapeutic Inc EV to EBITDA ratio is -1.20, with an EV/FCF ratio of -8.66.
EV to Sales19.90
EV to EBITDA-1.20
EV to Free Cash Flow-8.66
EV to Operating Cash Flow-8.66
Balance Sheet
Aion Therapeutic Inc has C$13.82K in cash and marketable securities with C$2.81M in debt, giving a net cash position of C$2.80M billion.
Cash & Marketable SecuritiesC$13.82K
Total DebtC$2.81M
Net CashC$2.80M
Net Cash Per Share<C$0.01
Tangible Book Value Per Share-C$0.01
Margins
Gross margin is 0.00%, with operating margin of -324.09%, and net profit margin of -1710.90%.
Gross Margin0.00%
Operating Margin-324.09%
Pretax Margin-1710.90%
Net Profit Margin-1710.90%
EBITDA Margin-1652.80%
EBIT Margin-1664.26%
Analyst Forecast
The average price target for Aion Therapeutic Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast563.34%
EPS Growth Forecast-68.82%